TickerFactsScreenerDevelopers

TScan Therapeutics, Inc. (TCRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2020: $34.79M2021: $161.41M2022: $120.03M2023: $133.36M2024: $178.69M2025: $152.41M$152.41M
2020Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$152.41M-14.7%
2024$178.69M+34.0%
2023$133.36M+11.1%
2022$120.03M-25.6%
2021$161.41M+363.9%
2020$34.79M—